[{"Year":2010,"Value":76,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2011,"Value":96,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2012,"Value":99,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2013,"Value":99,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2014,"Value":99,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2015,"Value":97,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2016,"Value":97,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2017,"Value":98,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2018,"Value":97,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2019,"Value":98,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2020,"Value":98,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2021,"Value":99,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2022,"Value":98,"Series":"Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)"},{"Year":2013,"Value":29,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2014,"Value":91,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2015,"Value":87,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2016,"Value":82,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2017,"Value":78,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2018,"Value":80,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2019,"Value":82,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2020,"Value":82,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2021,"Value":96,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2022,"Value":76,"Series":"Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)"},{"Year":2010,"Value":85,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2011,"Value":85,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2012,"Value":91,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2013,"Value":88,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2014,"Value":94,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2015,"Value":91,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2016,"Value":86,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2017,"Value":83,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2018,"Value":95,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2019,"Value":95,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2020,"Value":99,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2021,"Value":93,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2022,"Value":95,"Series":"Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)"},{"Year":2021,"Value":99,"Series":"Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)"},{"Year":2022,"Value":99,"Series":"Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%)"}]